Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B

被引:0
|
作者
Mio Tanaka
Fumitaka Suzuki
Yuya Seko
Tasuku Hara
Yusuke Kawamura
Hitomi Sezaki
Tetsuya Hosaka
Norio Akuta
Masahiro Kobayashi
Yoshiyuki Suzuki
Satoshi Saitoh
Yasuji Arase
Kenji Ikeda
Mariko Kobayashi
Hiromitsu Kumada
机构
[1] Toranomon Hospital,Department of Hepatology
[2] Toranomon Hospital,Research Institute for Hepatology
来源
关键词
Adefovir dipivoxil; Hepatitis B virus; Renal dysfunction; Hypophosphatemia; Fanconi’s syndrome; Osteomalacia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:470 / 480
页数:10
相关论文
共 50 条
  • [21] LONG-TERM ADEFOVIR DIPIVOXIL MONOTHERAPY FOR UP TO 5 YEARS IN LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B
    Lee, Jung Min
    Park, Jun Yong
    Kim, Do Young
    Nguyen, Tin
    Hong, Sunpyo
    Lee, Kwan Sik
    Moon, Byung Soo
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Moon, Young Myoung
    Ahn, Sang Hoon
    HEPATOLOGY, 2009, 50 (04) : 504A - 504A
  • [22] Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B
    Kim, D. Y.
    Lee, J. M.
    Ahn, S. H.
    Lee, Y. C.
    Lee, D. K.
    Chung, J. B.
    Chon, C. Y.
    Han, K-H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [23] Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance
    Perrillo, Robert P.
    Hann, Hie-Won
    Schiff, Eugene
    Mutimer, David
    Willems, Bernard
    Leung, Nancy
    Lee, William M.
    Dixon, Susan
    Woessner, Mary
    Brosgart, Carol L.
    Condreay, Lynn D.
    Gardner, Stephen D.
    HEPATOLOGY INTERNATIONAL, 2011, 5 (02) : 654 - 663
  • [24] The comparison of adefovir dipivoxil or combination with lamivudine in patients with lamivudine resistant chronic hepatitis B
    Ayaz, Celal
    Celen, M. Kemal
    Geyik, M. Faruk
    Bayan, Kadim
    Dal, Tuba
    Altindis, Mustafa
    JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S118 - S119
  • [25] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment
    You, J.
    Zhuang, L.
    Chen, H. Y.
    Feng, X.
    Kong, L.
    Lei, H.
    Ma, Y. L.
    Li, Y. L.
    Yang, W. B.
    Huang, J. H.
    Yan, S. M.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S30 - S30
  • [26] Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance
    Robert P. Perrillo
    Hie-Won Hann
    Eugene Schiff
    David Mutimer
    Bernard Willems
    Nancy Leung
    William M. Lee
    Susan Dixon
    Mary Woessner
    Carol L. Brosgart
    Lynn D. Condreay
    Stephen D. Gardner
    Hepatology International, 2011, 5 : 654 - 663
  • [27] HIGH RISK OF RENAL IMPAIRMENT AND ARTERIAL HYPERTENSION DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B
    Vigano, Mauro
    Lampertico, Pietro
    Iavarone, Massimo
    Tontini, Gion Eugenio
    Facchetti, Floriana
    Colombo, Massimo
    HEPATOLOGY, 2008, 48 (04) : 708A - 708A
  • [28] Efficacy and Safety of Long-term Adefovir Dipivoxil Therapy in Children With Chronic Hepatitis B Infection
    Jonas, Maureen M.
    Kelly, Deirdre
    Pollack, Henry
    Mizerski, Jacek
    Sorbel, Jeff
    Frederick, David
    Mondou, Elsa
    Rousseau, Franck
    Sokal, Etienne
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (06) : 578 - 582
  • [29] Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir
    Kwak, M. S.
    Choi, J. W.
    Lee, J. S.
    Kim, K. A.
    Suh, J. H.
    Cho, Y. S.
    Won, S. Y.
    Park, B. K.
    Lee, C. K.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : E432 - E438
  • [30] Two years efficiency of lamivudine and adefovir dipivoxil combined therapy in chronic hepatitis B patients
    Wang, H.
    Ji, Y. Y.
    Yao, G. B.
    Ma, X. Y.
    Xie, Q.
    Pang, H. Y.
    Wu, S. M.
    Li, J.
    Chen, C. W.
    Xu, X. W.
    Gu, E. L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (05) : 636 - 643